Effectiveness of Laser Hair Removal in Pilonidal Disease
- Conditions
- Pilonidal Disease
- Interventions
- Device: Laser depilationOther: Standard of care hair depilation
- Registration Number
- NCT03276065
- Lead Sponsor
- Nationwide Children's Hospital
- Brief Summary
Pilonidal disease is a common painful condition that affects 26 per 100,000 people with an incidence of 1.1% in the young male population. Recurrence rates of pilonidal disease after initial incision and drainage and after resection have been reported to be 16% and 11% respectively. Furthermore, wound issues after resection with primary closure have been reported to be as high as 30%. In several retrospective studies and small prospective studies, laser hair removal has shown promise as an adjunct therapy to decrease recurrent infections and decrease the need for repeat surgery in adults and older adolescents. We are performing a randomized control trial of laser hair depilation plus chemical/mechanical depilation to examine outcomes related to recurrence of pilonidal disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 302
- All Fitzpatrick skin types
- 11-21 years of age
- Diagnosis of pilonidal disease
- History of photosensitivity
- Actively inflamed pilonidal sinus. These patients are invited to participate upon resolution of their inflamed sinus.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Laser plus Standard of Care Depilation Laser depilation Laser depilation to the natal cleft (pilonidal region) every 4-6 weeks for 5 treatments with either an 810nm or Nd:YAG laser dependent on Fitzpatrick skin type and tolerability. Patients and families in the intervention group will also be taught hair removal techniques and asked to perform either chemical or mechanical depilation as needed to keep the area hair-free between clinic treatments. Standard of Care Depilation Standard of care hair depilation Patients and families in the standard of care group will be taught hair removal techniques and asked to perform either chemical or mechanical depilation as needed to keep the area hair-free. Patients will be given supplies for six months of hair removal.
- Primary Outcome Measures
Name Time Method Recurrence of pilonidal disease 12 months Recurrence is defined as a new development of pilonidal abscess, folliculitis, or draining sinus after treatment which would require antibiotic treatment, additional surgical incision and drainage or excision.
- Secondary Outcome Measures
Name Time Method Disability Days 12 months Defined as days that patient does participate in all normal activities due to their pilonidal disease
Health related quality of life 1 year Measured using PedsQL scales
Trial Locations
- Locations (1)
Nationwide Children's Hospital
🇺🇸Columbus, Ohio, United States